Posted by Michael Wonder on 24 Apr 2023
NICE collaborates with international partner agencies to streamline the confidential marking process
24 April 2023 - NICE, the Canadian Agency for Drugs and Technologies in Health and the US’s Institute for Clinical and Economic Review have today announced they are changing the way confidential information about health technologies is handled to streamline processes and increase transparency.
Health technology evaluations must strike a critical balance between ensuring transparency of the evidence and decision-making and protecting confidential information. The 3 organisations operate in different health systems but share common aims and values. Given these similarities, NICE, CADTH and ICER have been working together to create a more consistent approach to handling clinical data. Today they have published a joint statement setting out the changes.
